Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-144109

IMS Health Holdings, Inc. · Q

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Oct 3, 2016
Accepted (ET)
Oct 4, 2016 · 3:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595262

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5Oct 3, 2016D14,579,471$0.00D0D
Common StockF6,F2,F3,F4,F7Oct 3, 2016D4,373,491$0.00D0D
Common StockF8,F2,F3,F4,F9Oct 3, 2016D138,733$0.00D0D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Mr. John G. Danhakl was a member of the board of directors of the Issuer prior to the Conversion, and he is also an indirect limited partner of LGP, which is the manager of GEI V, GEI Side V and Peridot, and an affiliate of GEIC, Holdings, and Associates V (the "LGP Entities"). Accordingly, prior to the Conversion, Mr. Danhakl may have be deemed to represent the interests of the LGP Entities on the board of directors of the Issuer, and accordingly, the LGP Entities may have be deemed to be directors of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.